Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 8/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | DRD4 | P21917 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7451238 | 0.87 | DRD2 (0.51) | ALDH1A1CYP2D6CYP2C9ALOX15MAPK1 | |
| SCHEMBL8094410 | 0.86 | GRM2 (0.41) | CHRM5ALDH1A1TSHRCYP2D6CYP2C9 | |
| SCHEMBL7451624 | 0.85 | FYN (0.45) | ALDH1A1TSHRCYP2D6CYP2C9ALOX15 | |
| SCHEMBL7456278 | 0.83 | DRD3 (0.50) | ALDH1A1TSHRCYP2D6CYP2C9ALOX15 | |
| SCHEMBL8103965 | 0.82 | ALDH1A1 (0.55) | ALDH1A1TSHRCYP2D6CYP2C9ALOX15 | |
| SCHEMBL7409517 | 0.82 | ALDH1A1 (0.49) | ALDH1A1TSHRCYP2D6CYP2C9ALOX15 | |
| SCHEMBL7448699 | 0.81 | CA1 (0.49) | ALDH1A1CYP2D6CYP2C9ALOX15MAPK1 | |
| SCHEMBL7443295 | 0.80 | FYN (0.45) | ALDH1A1TSHRCYP2D6CYP2C9ALOX15 | |
| SCHEMBL7448204 | 0.80 | FYN (0.42) | ALDH1A1TSHRCYP2D6CYP2C9ALOX15 | |
| SCHEMBL7456004 | 0.79 | CA1 (0.56) | DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6084130-A | FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | PHARMACIA & UPJOHN COMPANY (US) | 2000-07-04 | — | — | US | disclosed |